Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
FEBS J ; 287(14): 2903-2913, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32191397

RESUMEN

Parathyroid hormone (PTH) regulates serum calcium levels and bone strength. Secondary hyperparathyroidism (SHP) is a common complication of chronic kidney disease (CKD) that correlates with morbidity and mortality. In experimental SHP, the increased PTH gene expression is due to increased PTH mRNA stability and is mediated by protein-PTH mRNA interactions. Adenosine-uridine-rich binding factor 1 (AUF1) stabilizes and K-homology splicing regulatory protein (KSRP) destabilizes PTH mRNA. The peptidyl-prolyl cis/trans isomerase Pin1 acts on target proteins, including mRNA-binding proteins. Pin1 leads to KSRP dephosphorylation, but in SHP, parathyroid Pin1 activity is decreased and phosphorylated KSRP fails to bind PTH mRNA, leading to increased PTH mRNA stability and levels. A further level of post-transcriptional regulation occurs through microRNA (miRNA). Dicer mediates the final step of miRNA maturation. Parathyroid-specific Dicer knockout mice that lack miRNAs in the parathyroid develop normally. Surprisingly, these mice fail to increase serum PTH in response to both hypocalcemia and CKD, indicating that parathyroid Dicer and miRNAs are essential for stimulation of the parathyroid. Human and rodent parathyroids share similar miRNA profiles that are altered in hyperparathyroidism. The evolutionary conservation of abundant miRNAs and their regulation in hyperparathyroidism indicate their significance in parathyroid physiology and pathophysiology. let-7 and miR-148 antagonism modifies PTH secretion in vivo and in vitro, suggesting roles for specific miRNAs in parathyroid function. This review summarizes the current knowledge on the post-transcriptional mechanisms of PTH gene expression in SHP and the central contribution of miRNAs to the high serum PTH levels of both primary hyperparathyroidism and SHP.


Asunto(s)
Regulación de la Expresión Génica , Hiperparatiroidismo Secundario/patología , Hormona Paratiroidea/genética , Procesamiento Postranscripcional del ARN , Insuficiencia Renal Crónica/patología , Animales , Humanos , Hiperparatiroidismo Secundario/genética , Hiperparatiroidismo Secundario/metabolismo , Hormona Paratiroidea/metabolismo , Insuficiencia Renal Crónica/genética , Insuficiencia Renal Crónica/metabolismo
2.
J Am Soc Nephrol ; 28(8): 2353-2363, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28298326

RESUMEN

Secondary hyperparathyroidism commonly complicates CKD and associates with morbidity and mortality. We profiled microRNA (miRNA) in parathyroid glands from experimental hyperparathyroidism models and patients receiving dialysis and studied the function of specific miRNAs. miRNA deep-sequencing showed that human and rodent parathyroids share similar profiles. Parathyroids from uremic and normal rats segregated on the basis of their miRNA expression profiles, and a similar finding was observed in humans. We identified parathyroid miRNAs that were dysregulated in experimental hyperparathyroidism, including miR-29, miR-21, miR-148, miR-30, and miR-141 (upregulated); and miR-10, miR-125, and miR-25 (downregulated). Inhibition of the abundant let-7 family increased parathyroid hormone (PTH) secretion in normal and uremic rats, as well as in mouse parathyroid organ cultures. Conversely, inhibition of the upregulated miR-148 family prevented the increase in serum PTH level in uremic rats and decreased levels of secreted PTH in parathyroid cultures. The evolutionary conservation of abundant miRNAs in normal parathyroid glands and the regulation of these miRNAs in secondary hyperparathyroidism indicates their importance for parathyroid function and the development of hyperparathyroidism. Specifically, let-7 and miR-148 antagonism modified PTH secretion in vivo and in vitro, implying roles for these specific miRNAs. These findings may be utilized for therapeutic interventions aimed at altering PTH expression in diseases such as osteoporosis and secondary hyperparathyroidism.


Asunto(s)
Hiperparatiroidismo Secundario/sangre , MicroARNs/fisiología , Hormona Paratiroidea/sangre , Animales , Hiperparatiroidismo Secundario/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratas , Ratas Sprague-Dawley
3.
Curr Opin Nephrol Hypertens ; 25(4): 271-7, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27138227

RESUMEN

PURPOSE OF REVIEW: Micro-RNAs (miRNAs) are important to the function of many cells including endocrine systems. We present the reported changes in miRNA profiles in parathyroid adenomas and carcinomas. We review the essential roles of parathyroid miRNAs to the response of the parathyroid to hypocalcemia and uremia. RECENT FINDINGS: miRNA profiling in parathyroid adenomas and carcinomas revealed alterations in their miRNA expression. To study the function of miRNAs in the parathyroid, mice with parathyroid-specific deletion of dicer, the enzyme essential for miRNA maturation, were studied. Remarkably, the parathyroid-Dicer mice failed to increase serum parathyroid hormone (PTH) after acute hypocalcemia and in parathyroid organ cultures. Moreover, the parathyroid-Dicer mice had an impaired increase in serum PTH, PTH mRNA and parathyroid cell proliferation after both chronic hypocalcemia and uremia. In contrast, the response of the parathyroid- Dicer mice to hypercalcemia and a calcimimetic was intact. SUMMARY: The stimulation of the parathyroid by hypocalcemia and uremia is miRNA dependent, as opposed to suppression of the parathyroid by hypercalcemia or a calcimimetic that is miRNA independent. miRNAs are essential for the generation of experimental secondary hyperparathyroidism and may be novel targets for its management in chronic kidney disease patients.


Asunto(s)
Adenoma/metabolismo , Carcinoma/metabolismo , Hiperparatiroidismo Secundario/metabolismo , Hipocalcemia/metabolismo , MicroARNs/metabolismo , Glándulas Paratiroides/metabolismo , Hormona Paratiroidea/metabolismo , Neoplasias de las Paratiroides/metabolismo , Uremia/metabolismo , Animales , Calcio/metabolismo , ARN Helicasas DEAD-box/genética , Humanos , Hipercalcemia/metabolismo , Ratones , Ratones Noqueados , Hormona Paratiroidea/genética , ARN Mensajero , Ribonucleasa III/genética
4.
FASEB J ; 29(9): 3964-76, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26054367

RESUMEN

MicroRNAs (miRNAs) down-regulate gene expression and have vital roles in biology but their functions in the parathyroid are unexplored. To study this, we generated parathyroid-specific Dicer1 knockout (PT-Dicer(-/-) ) mice where parathyroid miRNA maturation is blocked. Remarkably, the PT-Dicer(-/-) mice did not increase serum parathyroid hormone (PTH) in response to acute hypocalcemia compared with the >5-fold increase in controls. PT-Dicer(-/-) glands cultured in low-calcium medium secreted 5-fold less PTH at 1.5 h than controls. Chronic hypocalcemia increased serum PTH >4-fold less in PT-Dicer(-/-) mice compared with control mice with no increase in PTH mRNA levels and parathyroid cell proliferation compared with the 2- to 3-fold increase in hypocalcemic controls. Moreover, uremic PT-Dicer(-/-) mice increased serum PTH and FGF23 significantly less than uremic controls. Therefore, stimulation of the parathyroid by both hypocalcemia and uremia is dependent upon intact dicer function and miRNAs. In contrast, the PT-Dicer(-/-) mice responded normally to activation of the parathyroid calcium-sensing receptor (Casr) by both hypercalcemia and a calcimimetic that decreases PTH secretion, demonstrating that they are dicer-independent. Therefore, miRNAs are essential for the response of the parathyroid to both acute and chronic hypocalcemia and uremia, the major stimuli for PTH secretion.


Asunto(s)
ARN Helicasas DEAD-box/metabolismo , Hipocalcemia/metabolismo , MicroARNs/metabolismo , Glándulas Paratiroides/metabolismo , Hormona Paratiroidea/metabolismo , Ribonucleasa III/metabolismo , Uremia/metabolismo , Enfermedad Aguda , Animales , Enfermedad Crónica , ARN Helicasas DEAD-box/genética , Factor-23 de Crecimiento de Fibroblastos , Factores de Crecimiento de Fibroblastos/genética , Factores de Crecimiento de Fibroblastos/metabolismo , Hipocalcemia/genética , Hipocalcemia/patología , Ratones , Ratones Noqueados , MicroARNs/genética , Glándulas Paratiroides/patología , Hormona Paratiroidea/genética , Receptores Sensibles al Calcio , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Ribonucleasa III/genética , Uremia/genética , Uremia/patología
5.
PLoS One ; 7(9): e45532, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23049812

RESUMEN

Teratoma tumor formation is an essential criterion in determining the pluripotency of human pluripotent stem cells. However, currently there is no consistent protocol for assessment of teratoma forming ability. Here we present detailed characterization of a teratoma assay that is based on subcutaneous co-transplantation of defined numbers of undifferentiated human embryonic stem cells (hESCs) with mitotically inactivated feeder cells and Matrigel into immunodeficient mice. The assay was highly reproducible and 100% efficient when 100,000 hESCs were transplanted. It was sensitive, promoting teratoma formation after transplantation of 100 hESCs, though larger numbers of animals and longer follow-up were required. The assay could detect residual teratoma forming cells within differentiated hESC populations however its sensitivity was decreased in the presence of differentiated cells. Our data lay the foundation, for standardization of a teratoma assay for pluripotency analysis. The assay can also be used for bio-safety analysis of pluripotent stem cell-derived differentiated progeny.


Asunto(s)
Bioensayo/normas , Células Madre Embrionarias/patología , Células Madre Pluripotentes/patología , Teratoma/patología , Animales , Biomarcadores/metabolismo , Recuento de Células , Diferenciación Celular , Colágeno/administración & dosificación , Combinación de Medicamentos , Células Madre Embrionarias/trasplante , Células Nutrientes/citología , Células Nutrientes/trasplante , Fibroblastos/citología , Fibroblastos/trasplante , Humanos , Inyecciones Subcutáneas , Cariotipificación , Laminina/administración & dosificación , Ratones , Ratones Endogámicos NOD , Ratones SCID , Células Madre Pluripotentes/trasplante , Proteoglicanos/administración & dosificación , Sensibilidad y Especificidad , Tasa de Supervivencia , Teratoma/mortalidad
6.
Am J Nephrol ; 28(5): 831-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18535369

RESUMEN

BACKGROUND/AIM: Diabetes leads to chronic renal hypoxia and cellular hypoxia response (mediated by hypoxia-inducible factors) and predisposes to acute kidney injury. We studied the impact of acute and chronic hypoxic stress on the development of acute kidney injury in the diabetic rat kidney. METHODS: Control (CTR) and streptozotocin (STZ)-diabetic rats were studied following acute medullary hypoxic stress, induced by combinations of radiocontrast and inhibitors of cyclooxygenase and NO synthase. In addition, STZ and CTR kidneys were compared following ex vivo perfusion with oxygenated cell-free medium. RESULTS: The extents of medullary acute tubular injury and renal dysfunction were largely comparable in CTR and STZ-diabetic kidneys in vivo. By contrast, functional deterioration and outer medullary injury were markedly enhanced in STZ kidneys perfused ex vivo. A peculiar collecting duct injury pattern, with cell swelling and detachment, noted in intact STZ kidneys, prominently intensified following isolated perfusion. CONCLUSIONS: The diabetic kidney is remarkably resistant to acute hypoxic injury in vivo, possibly due to chronic hypoxia adaptation. Thus, though diabetes predisposes to acute kidney injury in various clinical settings, reduced kidney function does not necessarily imply a greater extent of true tubular damage. The collecting duct injury pattern is an as yet unrecognized feature of early experimental diabetes.


Asunto(s)
Diabetes Mellitus Experimental/complicaciones , Nefropatías Diabéticas/etiología , Animales , Hipoxia de la Célula , Diabetes Mellitus Experimental/fisiopatología , Nefropatías Diabéticas/patología , Nefropatías Diabéticas/fisiopatología , Técnicas In Vitro , Riñón/patología , Masculino , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA